顧みられない熱帯病治療市場：製品タイプ別、疾患タイプ別、診断方法別-2025-2030年の世界予測

顧みられない熱帯病治療市場は、2023年に61億3,000万米ドルと評価され、2024年には64億米ドルに達すると予測され、CAGR 6.25％で成長し、2030年には93億8,000万米ドルに達すると予測されています。

顧みられない熱帯病（Neglected Tropical Diseases：NTDs）は、主に熱帯地域の貧困層が罹患し、深刻な罹患率と社会的スティグマをもたらす疾患群です。NTDsの治療は、人々の健康、経済生産性、社会構造に多大な影響を及ぼすため、包括的な取り組みが必要です。その範囲は、医療介入、媒介蚊の駆除、公衆衛生キャンペーン、地域社会教育など多岐にわたる。ワクチン、治療薬、診断ツールへの応用も含まれます。最終用途は、政府の保健機関から非営利団体、医薬品開発や流通に携わる民間企業まで多岐にわたる。市場成長は、認知度の向上、流行地域のヘルスケアインフラの改善、医薬品研究と生産を促進する官民パートナーシップの影響下にあります。潜在的なビジネスチャンスは、創薬技術の進歩、国際機関からの投資の増加、より広範なカバー範囲とオーダーメイド治療を目指した戦略的提携にあります。これらを活用するために、利害関係者は研究開発能力の強化、セクターを超えた協力関係の強化、効率的な疾病追跡と患者管理のためのデジタルヘルス技術の活用に注力すべきです。

しかし、市場は、迅速な医薬品承認と流通の妨げとなるインフラの不備、低資金、厳格な規制管理による制約に直面しています。NTDsの影響を最も受けている地域の政情不安は、介入策を提供する努力をさらに複雑にしています。革新的な研究は、個別化医療のための病原体ゲノミクス、アクセシビリティを向上させる新しいドラッグデリバリー・システム、治療と予防措置を組み合わせた統合的アプローチの開発に焦点を当てることができます。国際的なサプライチェーンへの依存を減らすため、費用対効果の高い生産技術や現地に根ざした製造ソリューションを模索することで、事業の成長を促進することができます。NTD治療市場の性質は、ヘルスケアの進歩と世界の政策シフトが交錯するダイナミックなものであり、進化する課題に対応するための機敏な戦略が求められます。市場開拓に取り組む企業は、持続可能な成長とインパクトを達成するために、技術革新に後れを取らず、国際的な協力関係を強化し、現地のニーズや状況に即した製品やサービスを開発するボトムアップ・アプローチを採用することをお勧めします。

市場力学：急速に進化する顧みられない熱帯病治療市場の主要市場インサイトを公開

顧みられない熱帯病治療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 顧みられない熱帯病治療に対する意識の高まり
  • 熱帯・亜熱帯諸国における顧みられない熱帯病の負担増
  • 研究開発への巨額の投資
• 市場抑制要因
  • 薬剤の副作用
• 市場機会
  • 治療に対する政府の好意的な取り組み
  • 治療プログラムにおける研究開発と新発売への投資の増加
• 市場の課題
  • 診断と治療のための標準化ツールの欠如

ポーターのファイブフォース：顧みられない熱帯病治療市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：顧みられない熱帯病治療市場における外部からの影響の把握

外部マクロ環境要因は、顧みられない熱帯病治療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析顧みられない熱帯病治療市場における競合情勢の把握

顧みられない熱帯病治療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス顧みられない熱帯病治療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、顧みられない熱帯病治療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨顧みられない熱帯病治療市場における成功への道筋を描く

顧みられない熱帯病治療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 顧みられない熱帯病の治療に対する意識の高まり
    • 熱帯・亜熱帯諸国における無視されがちな熱帯病の負担が増大
    • 研究開発への巨額の資金投資
  • 抑制要因
    • 薬の副作用
  • 機会
    • 治療に対する政府の好意的な取り組み
    • 研究開発への投資の増加と治療プログラムの新規導入
  • 課題
    • 診断と治療のための標準化ツールの欠如
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 顧みられない熱帯病治療市場：製品別

• 薬物
• ワクチン

第7章 顧みられない熱帯病治療市場病気の種類別

• ブルーリ潰瘍
• シャーガス病
• デング熱
• ヒトアフリカトリパノソーマ症
• リーシュマニア症
• ハンセン病
• 狂犬病
• 土壌伝播性蠕虫病
• トラコーマ
• イチゴ腫

第8章 顧みられない熱帯病治療市場診断方法別

• 従来型
• 分子/現代

第9章 南北アメリカの顧みられない熱帯病治療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の顧みられない熱帯病治療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの顧みられない熱帯病治療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Amneal Pharmaceuticals LLC
• Bayer AG
• Daiichi Sankyo Company, Limited
• Eisai Co., Ltd.
• F. Hoffmann-La Roche Ltd
• Insud Pharma, S.L.
• Novartis AG
• Oblita Therapeutics
• Omega Diagnostics Group PLC
• Oscar Medicare Pvt Ltd.
• Sanofi S.A
• Teva Pharmaceutical Industries Ltd
• Themis Bioscience GmbH
• Valneva SE
• ZeptoMetrix, LLC

LIST OF FIGURES

• FIGURE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET RESEARCH PROCESS
• FIGURE 2. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. NEGLECTED TROPICAL DISEASE TREATMENT MARKET DYNAMICS
• TABLE 7. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY BURULI ULCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CHAGAS DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DENGUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY HUMAN AFRICAN TRYPANOSOMIASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEISHMANIASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY LEPROSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY RABIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY SOIL-TRANSMITTED HELMINTHIASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TRACHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY YAWS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY MOLECULAR/MODERN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 34. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 36. CANADA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 51. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 53. CHINA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 54. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 56. INDIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 106. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 108. ITALY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 118. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 120. POLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 121. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 123. QATAR NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY TYPES OF DISEASES, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM NEGLECTED TROPICAL DISEASE TREATMENT MARKET SIZE, BY DIAGNOSTIC METHOD, 2018-2030 (USD MILLION)
• TABLE 151. NEGLECTED TROPICAL DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 152. NEGLECTED TROPICAL DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

The Neglected Tropical Disease Treatment Market was valued at USD 6.13 billion in 2023, expected to reach USD 6.40 billion in 2024, and is projected to grow at a CAGR of 6.25%, to USD 9.38 billion by 2030.

Neglected Tropical Diseases (NTDs) encompass a group of conditions primarily affecting impoverished populations in tropical regions, resulting in significant morbidity and social stigma. NTD treatment necessitates comprehensive efforts due to their profound impact on human health, economic productivity, and social structure. The scope encompasses medical intervention, vector control, public health campaigns, and community education. Applications include use in vaccines, therapeutic drugs, and diagnostic tools. End-use ranges from governmental health agencies to non-profits and private sector players involved in drug development and distribution efforts. Market growth is influenced by increased awareness, improved healthcare infrastructure in endemic regions, and public-private partnerships fostering pharmaceutical research and production. Potential opportunities lie in technological advancements in drug discovery, rising investments from international organizations, and strategic alliances aimed at broader coverage and tailored treatments. To capitalize on these, stakeholders should focus on enhancing R&D capabilities, reinforcing collaborations across sectors, and leveraging digital health technologies for efficient disease tracking and patient management.

However, the market faces limitations due to infrastructural inadequacies, low funding, and stringent regulatory controls, which hinder swift drug approval and distribution. Political instability in regions most affected by NTDs further complicates efforts to deliver interventions. Innovative research can focus on pathogen genomics for personalized medicine, novel drug delivery systems to improve accessibility, and developing integrated approaches combining treatment with preventive measures. Business growth can be bolstered by exploring cost-effective production technologies and localized manufacturing solutions to reduce dependency on international supply chains. The nature of the NTD treatment market is dynamic, driven by the intersection of healthcare advances and global policy shifts, requiring agile strategies to address evolving challenges. Market players are advised to stay abreast of technological innovations, strengthen international collaborations, and adopt a bottom-up approach in developing products and services aligned with local needs and conditions, to achieve sustainable growth and impact.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neglected Tropical Disease Treatment Market

The Neglected Tropical Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising awareness of neglected tropical diseases treatments
  • Increasing burden of neglected tropical disease in tropical and subtropical countries
  • Huge financial investment in research & development
• Market Restraints
  • Side effects of the drugs
• Market Opportunities
  • Favorable government initiatives for the treatment
  • Increasing investments in R&D and new launches in the treatment programs
• Market Challenges
  • Lack of standardization tools for diagnosis and treatment

Porter's Five Forces: A Strategic Tool for Navigating the Neglected Tropical Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neglected Tropical Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neglected Tropical Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neglected Tropical Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neglected Tropical Disease Treatment Market

A detailed market share analysis in the Neglected Tropical Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neglected Tropical Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neglected Tropical Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neglected Tropical Disease Treatment Market

A strategic analysis of the Neglected Tropical Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neglected Tropical Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include Amneal Pharmaceuticals LLC, Bayer AG, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd, Insud Pharma, S.L., Novartis AG, Oblita Therapeutics, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd., Sanofi S.A, Teva Pharmaceutical Industries Ltd, Themis Bioscience GmbH, Valneva SE, and ZeptoMetrix, LLC.

Market Segmentation & Coverage

This research report categorizes the Neglected Tropical Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Drugs and Vaccines.
• Based on Types of Diseases, market is studied across Buruli Ulcer, Chagas Disease, Dengue, Human African trypanosomiasis, Leishmaniases, Leprosy, Rabies, Soil-transmitted Helminthiases, Trachoma, and Yaws.
• Based on Diagnostic Method, market is studied across Conventional and Molecular/Modern.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness of neglected tropical diseases treatments
    • 5.1.1.2. Increasing burden of neglected tropical disease in tropical and subtropical countries
    • 5.1.1.3. Huge financial investment in research & development
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects of the drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable government initiatives for the treatment
    • 5.1.3.2. Increasing investments in R&D and new launches in the treatment programs
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of standardization tools for diagnosis and treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neglected Tropical Disease Treatment Market, by Product

• 6.1. Introduction
• 6.2. Drugs
• 6.3. Vaccines

7. Neglected Tropical Disease Treatment Market, by Types of Diseases

• 7.1. Introduction
• 7.2. Buruli Ulcer
• 7.3. Chagas Disease
• 7.4. Dengue
• 7.5. Human African trypanosomiasis
• 7.6. Leishmaniases
• 7.7. Leprosy
• 7.8. Rabies
• 7.9. Soil-transmitted Helminthiases
• 7.10. Trachoma
• 7.11. Yaws

8. Neglected Tropical Disease Treatment Market, by Diagnostic Method

• 8.1. Introduction
• 8.2. Conventional
• 8.3. Molecular/Modern

9. Americas Neglected Tropical Disease Treatment Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neglected Tropical Disease Treatment Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neglected Tropical Disease Treatment Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amneal Pharmaceuticals LLC
• 2. Bayer AG
• 3. Daiichi Sankyo Company, Limited
• 4. Eisai Co., Ltd.
• 5. F. Hoffmann-La Roche Ltd
• 6. Insud Pharma, S.L.
• 7. Novartis AG
• 8. Oblita Therapeutics
• 9. Omega Diagnostics Group PLC
• 10. Oscar Medicare Pvt Ltd.
• 11. Sanofi S.A
• 12. Teva Pharmaceutical Industries Ltd
• 13. Themis Bioscience GmbH
• 14. Valneva SE
• 15. ZeptoMetrix, LLC